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24 
25 
Abstract 26 
Background: Mechanisms for the development of food allergy in neonates are unknown but are 27 
clearly linked in patient populations to a genetic predisposition towards skin barrier defects. 28 
Whether skin barrier defects functionally contribute to development of food allergy is unknown. 29 
Objective: The purpose of the study was to determine whether skin barrier mutations, that are 30 
primarily heterozygous in patient populations, contribute to the development of food allergy.  31 
Methods: Mice heterozygous for the Flgft and Tmem79ma mutations were skin sensitized with 32 
environmental allergens and food allergens.  After sensitization, mice received oral challenge with 33 
food allergen and then inflammation, inflammatory mediators, and anaphylaxis were measured.   34 
Results: We define development of inflammation, inflammatory mediators, and food allergen-35 
induced anaphylaxis in neonatal mice with skin barrier mutations following brief concurrent 36 
cutaneous exposure to food and environmental allergens.  Moreover, neonates of allergic mothers 37 
have elevated responses to suboptimal sensitization with food allergens. Importantly, the 38 
responses to food allergens by these neonatal mice were dependent on genetic defects in skin 39 
barrier function and on exposure to environmental allergens. Blockade of ST2 during skin 40 
sensitization inhibited development of anaphylaxis, antigen-specific IgE and inflammatory 41 
mediators. The neonatal anaphylactic responses and antigen-specific IgE were also inhibited by 42 
oral pre-exposure to food allergen but, interestingly, this was blunted by concurrent pre-exposure 43 
of the skin to environmental allergen.  44 
Conclusion:  These studies uncover mechanisms for food allergy sensitization and anaphylaxis in 45 
neonatal mice that are consistent with features of human early life exposures and genetics in 46 
clinical food allergy and demonstrate that changes in barrier function drive development of 47 
anaphylaxis to food allergen. 48 
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Key Messages 50 
● In neonatal mice, concurrent skin exposure with food and environmental allergens leads to51 
induction of food allergy before clinical manifestations of atopic dermatitis. 52 
● Neonatal pups with heterozygous skin barrier mutations from WT allergic mothers, have elevated53 
food allergen sensitization, inflammatory mediators, and anaphylaxis to food allergen challenge, 54 
compared to offspring of non-allergic mothers or offspring without skin barrier mutations. 55 
● Blockade of ST2 during skin sensitization inhibited anaphylaxis and inflammatory mediators.56 
● In neonates, tolerance to food allergens is blunted by concurrent pre-exposure of the skin to57 
environmental allergen while oral pre-exposure to food allergen. 58 
59 
Capsule summary.60 
Food allergy develops in neonates with skin barrier mutations and brief concurrent cutaneous 61 
exposure to food and environmental allergens and this was inhibited by blockade of ST2. In 62 
neonates with skin barrier mutations, oral food allergen-induced tolerance is blunted by cutaneous 63 
exposure to environmental allergens. 64 
65 
Abbreviations. 66 
Alt, Alternaria alternata extract; CT, cholera toxin (CT); Flg, filaggrin; FT+/-; Flaky tail mice 67 
heterozygous for filaggrin mutation and heterozygous for mattrin mutation; FT-/-; Flaky tail mice 68 
with homozygous filaggrin mutation and homozygous mattrin mutation; HDM, house dust mite; 69 
LEAP, Learning Early about Allergy to Peanut trial; Matt, mattrin; OVA, chicken egg ovalbumin 70 
fraction V; PND, postnatal day; PNE, peanut extract; SEB, staphylococcal enterotoxin B; ST2, IL-71 
33 receptor; TSLP, thymic stromal lymphopoietin; WT, wild type; 3ss, 3 skin sensitizations; 6ss, 6 72 
skin sensitizations 73 
74 
75 
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Introduction 76 
Acute allergic responses range from mild itching in mouth, hives, abdominal discomfort, to 77 
severe life-threatening anaphylaxis. There is no cure. Therapy includes strict avoidance of the food 78 
allergens and management of reactions with use of epinephrine for accidental consumption, 79 
though recent efforts in tolerance induction have shown some promise. Food allergy prevalence 80 
reports indicate 6% in young children have food allergies and up to an 18% increase in prevalence 81 
from 1997 and 2007 1-3.  82 
Food allergies often develop early in life. Offspring of allergic mothers or fathers have 83 
increased incidence of food allergies 4. The risk for allergic disease in humans is associated with in 84 
utero and early exposures to environmental factors 5. In animal studies, we and others have 85 
reported that offspring from allergic mothers are predisposed to allergic lung responses to 86 
suboptimal allergen doses 6-15.  It is not known whether offspring of allergic mother mice have 87 
increased responsiveness to sensitization to food allergens and food-induced anaphylaxis.88 
In adult mouse models of food allergy, tolerance to food antigens is broken by oral 89 
administration of food antigens with cholera toxin (CT) 16-19 or staphylococcal enterotoxin B (SEB) 90 
20
. However, cholera is not prevalent in individuals with food allergies. Moreover, cholera outbreaks91 
have not occurred in the countries with prevalent food allergies 21-25. For SEB, the induction of food 92 
allergy by oral co-administration of food antigen and SEB is reported by some 20 but not others 26 to 93 
break tolerance to food antigens in wild type mice. The CT and SEB models have been used to 94 
examine approaches for inhibition of established food allergy. However, mechanisms for 95 
development of food allergy from environmental exposure are not known. 96 
Early in life, food allergy is often associated with atopic dermatitis. Atopic dermatitis results 97 
in skin barrier dysfunction and itchy, red, swollen, and cracked skin. Early-onset of atopic 98 
dermatitis is associated with increased risk of allergic sensitization to food allergens by age 2 and 99 
asthma by age 7 27, 28. Moreover, IgE-mediated food allergy is observed in up to 35% in children 100 
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affected with atopic dermatitis 29. This suggests that interventions early in life may influence the 101 
association of atopic dermatitis with food allergies 30. 102 
Atopic dermatitis in humans is associated with mutations in the skin barrier genes SPINK5, 103 
a serine peptidase inhibitor, CDSN, a structural protein of corneodesmosomes in the stratum 104 
corneum, Flg, filaggrin, a filament-associated protein that crosslinks keratin fibers in keratinocytes 105 
31
 and Matt, mattrin a transmembrane protein involved in stratum corneum barrier function 32.  106 
Whether atopic patients without these skin barrier mutations have other unidentified mutations is 107 
not known.  Filaggrin expression in keratinocytes can also be decreased during inflammation with 108 
IL-4 and IL-13 expression 33.  Several Flg mutations are a risk factor for development of allergies 34, 109 
35
, including peanut allergy 36, 37.  Flg and Matt genes affect skin barrier function. Mutations in both 110 
of these genes predispose humans and mice to atopic dermatitis 32. Flaky tail mice, with mutations 111 
in Flg (Flgft) and Matt (Tmem79ma) 32, are used in studies of the generation of localized sites of 112 
atopic dermatitis, skin allergic responses and lung asthmatic responses 34, 38-40. A report indicates 113 
that transcriptomes for inflammation vary between unchallenged flaky tail mice and Atopic 114 
Dermatitis patients 41, but it is important to appreciate the differences in skin exposures and thus 115 
stimulation for humans versus mice in barrier facilities. Although it is speculated that decreased 116 
barrier function increases exposure to allergens, it is not known how skin barrier mutations impact 117 
sensitization to food allergens. 118 
Atopic dermatitis and allergies are associated with fungal and house dust mite exposure 42. 119 
House dust mites, the fungal allergen Alternaria alternata and food antigens such as peanuts are 120 
present in house dust 43-47. House dust mite is a ubiquitous indoor allergen and the fungal allergen 121 
Alternaria alternata is a ubiquitous indoor and outdoor allergen to which neonates are exposed. 122 
Healthy and atopic dermatitis skin possess the fungi Alternaria and Malassezia 48. Fungal extracts 123 
exhibit broad cross-reactivity among fungi 42. Compared to healthy individuals, patients with atopic 124 
dermatitis show a higher frequency of IgE reactivity to the skin yeast Malassezia 49-51 and the 125 
allergen house dust mite 51. Atopic dermatitis patients can also have Alternaria-reactive IgE 52. The 126 
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mechanisms for these associations with atopic dermatitis are unclear but may be attributed to a 127 
combination of dysfunctional skin barrier, genetics, and environmental exposures early in life 49. 128 
In humans, expression of skin barrier mutations is predominantly heterozygous 53. Thus, we 129 
used FT mice as a representative of skin barrier defects. Heterozygous FT+/- were used where the 130 
“-“ indicates the presence of the mutation. In our studies, neonatal FT+/- mice developed allergic 131 
skin responses with increased Th2 cytokines, chemokines, and antigen-specific IgE after skin 132 
sensitization with peanut or chicken egg ovalbumin and co-exposure to Alternaria alternata or 133 
house dust mite. These sensitized neonates had anaphylaxis in response to oral gavage with the 134 
food antigen. The responses required the heterozygous expression of the skin barrier mutations 135 
and required the co-stimulation with Alternaria alternata or house dust mite extract. Blockade of 136 
ST2 during skin sensitization inhibited anaphylaxis and inflammatory mediators. Interestingly, the 137 
FT+/- offspring of allergic wild type mothers had elevated responses to suboptimal skin challenges 138 
as compared to FT+/- offspring of non-allergic wild type mothers. In addition, skin pre-exposure to 139 
Alt reduced tolerance induced by oral pre-exposure to food allergen. These mechanistic studies 140 
reflect early life exposures to allergens and genetic mutations that are consistent with the clinical 141 
manifestations of the development of food allergies.142 
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Materials and Methods 143 
Mice. C57BL/6J mice were from Jackson Laboratories, Bar Harbor, Maine. Flaky tail mice (FT-/-144 
mice) with homozygous mutations in Flgft/ft/Tmem79ma/ma and housed under specific pathogen-free 145 
barrier conditions. The Flaky tail mice on the C57BL/6 background have been previously described 146 
32, 34, 38-40
. The mouse bedding was ¼ inch Coarse Aspen Sani Chips (catalog #7115, Harlan Lab) 147 
and the diet was Teklad Irradiated LM-485 mouse diet (catalog #7912, Teklad). All mice were 148 
randomly selected for the studies. The studies are approved by the Northwestern University 149 
Institutional Review Committee for animals. 150 
151 
Allergens. Alternaria alternata extract (Alt, catalog #XPM1D3A2.5) and house dust mite (HDM) 152 
extract (Dermatophagoides pteronyssius extract, catalog #XPB82D3A2.5) were from Greer Labs. 153 
These are standard extracts from GREER used for patient immunotherapy. Chicken egg 154 
ovalbumin fraction V (OVA, catalog # 9006-59-1) was from Sigma. To generate peanut extract 155 
(PNE), peanuts (Planters Lightly Salted Dry Roasted Peanuts) were ground and then 25g were 156 
homogenized in 250ml of 20 mM Tris buffered (pH 7.2) saline (TBS) 54. This was stirred for 2 157 
hours at room temperature and centrifuged at 3000 g for 30 min. The aqueous middle layer was 158 
collected and centrifuged at 1600 g for 45 min to remove residual particles and fat. The aqueous 159 
layer was collected. Protein concentrations were determined by Pierce BCA Protein Assay Kit 160 
(Thermo Fisher Sci). Aliquots were stored at -20oC. SDS-PAGE after co-incubation of the 161 
allergens in vitro was performed as described in the Supplemental Methods. 162 
163 
Allergen sensitization. 164 
A. Generation of allergic mothers. Female mice at 4-6 weeks old were sensitized by165 
intraperitoneal injection (200 µl) of OVA grade V (5 µg)/alum (1mg) or saline/alum (1mg) on days 0 166 
and 7 6-8, 14, 15, 55 and then received nebulized saline or 3% (w/v) OVA in saline for 20 min three 167 
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times a week on weeks 4, 8, 12, and 16 weeks. At the last challenge on week 16, allergic or non-168 
allergic female mice were mated with 3 to 4 month old wild type or homozygous flaky tail (FT-/-) 169 
non-allergic males.  170 
B. Treatment of offspring. FT+/- offspring of the mating of wild type (WT) C57BL/6 females with171 
FT-/- males were confirmed by genotyping (Supplemental Methods).  At 3 days old, pups were 172 
gently taped five times on the back with 3M surgical hypoallergenic paper tape and wiped once 173 
with 4% SDS in sterile deionized water 56 on a sterile gauze. After 3 minutes, Alt extract or HDM 174 
extract (10 µg protein in 5 µl sterile saline) was applied to the pup skin and then, immediately PNE 175 
or OVA (100 µg protein in 10 µl sterile saline) was applied to the same area on the back. The pups 176 
were placed in a cage without the mother for 40 minutes 57. Then to prevent antigen consumption 177 
during grooming by the mother, the pups were washed gently with water on a paper towel and 178 
wiped dry to remove free antigen from the surface 57 before placing the pups back with the mother. 179 
The antigen applications were repeated 1 to 2 times per week as indicated in the figures, but on 180 
pups that are older than 5 days, the fur was shaved before tape stripping. The taping did not 181 
overtly disrupt the skin but gently removed dried skin after birth or hair after shaving (Supplement 182 
Fig 1).  183 
C. Tolerance induction. In studies with oral tolerance, pups received 100 µl of 10 mg/ml PNE by184 
gavage on 4 days before skin sensitization as indicated in the Figure. 185 
D. Blockade of ST2. For the pups treated with anti-ST2 (catalog # MAB10041, R&D Systems,186 
Inc) or isotype control (catalog #400544, Biolegend), the pups received an intraperitoneal injection 187 
of 8 µg antibody in saline per g pup at 1 hr before skin sensitization #1, 12 µg antibody/g pup at 1 188 
hr before skin sensitization #2 and #3, and then 15 µg antibody/g pup at 1 hr before skin 189 
sensitization #4. 190 
191 
Oral Antigen Challenge, Anaphylaxis and Tissue Analysis. At 48 hours after the last allergen 192 
skin sensitization indicated in the figure timelines, baseline rectal temperatures of the pups were 193 
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taken using a BAT-12 Microprobe Thermometer with a RET-4 thermocouple sensor type T rectal 194 
probe for neonatal mice (Physitemp Instruments Inc). Then, the pups received PNE or OVA by 195 
gavage (100 µl of 10 mg protein/ml sterile saline) using a 24 gauge gavage needle (Pet Surgical, 196 
Agoura Hills, CA). Rectal temperatures were taken every 15-20 minutes for up to 105 minutes. The 197 
pups were placed back with the mothers until pups were euthanized and tissues collected. Tissue 198 
sections were stained for eosinophils and mast cells or examined by qRT-PCR for inflammatory 199 
mediators (Supplemental methods). Eosinophils and mast cells in tissue sections were counted by 200 
light microscopy in 10 high powered fields in a blinded fashion. Serum anti-peanut antibodies (IgE, 201 
IgG2b, IgG1, and IgA), serum anti-OVA antibodies, and Mcpt-1 were determined by ELISA 202 
(Supplemental Methods). Endotoxin was measured using a chromogenic quantitation kit 203 
(Supplemental Methods). 204 
205 
Statistics. Data were analyzed by a one way ANOVA followed by Tukey’s multiple comparisons 206 
test or T-test (SigmaStat, Jandel Scientific, San Ramon, CA). Presented are the means ± the 207 
standard errors. The statistical analysis for the change in temperature was done using the 208 
maximum change in temperature.  The data in the figures include both genders for the offspring 209 
because there were no differences in outcomes by gender (Supplement Figure 2). 210 
211 
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Results 212 
Skin sensitization of neonates with skin barrier gene mutations induced responsiveness to 213 
oral food allergen-induced anaphylaxis. Because humans are predominantly heterozygous for 214 
skin barrier mutations, skin of neonatal mice with heterozygous mutations were exposed to 215 
environmental allergens and food allergens. Flaky Tail (FT) mice were used as a model 216 
representative of skin barrier mutations. Briefly, wild type female mice were bred with male FT-/- 217 
mice that are homozygous for the filaggrin flaky tail (ft) mutation and Tmem79 ma mutation, 218 
yielding offspring heterozygous FT+/- pups for both the Flgft and Tmem79ma mutations (Fig 1A). 219 
Pups were sensitized, on postnatal day (PND) 3 and then every 2-3 days (Fig 1A). To remove dry 220 
shedding skin after birth or fur after shaving, the pup skin received 5 gentle tape applications with 221 
3M Micropore paper hypoallergenic surgical paper tape, a gentle, non-irritating general purpose 222 
paper tape that is gentle to the skin, resulting in very little trauma to the neonate skin (Supplement 223 
Figure 1); this is in contrast to the skin trauma induced by more adhesive tapes such as 3M 224 
Tegaderm adhesive film 58. For applications after PND9, the pups were shaved to remove fur 225 
which can induce small nicks (Supplement Figure 1), analogous to infant scratching with atopic 226 
dermatitis. This skin site was then wiped once with 4% SDS in water which resembles cleansing 227 
wipe use on infants. Then, the pups received cutaneous application of Alternaria alternata extract 228 
(ALT), house dust mite extract (HDM), ALT with HDM or saline Figure 1A and B and Supplement 229 
Figure 2A and B. Immediately after this, a food allergen, peanut extract (PNE) (Fig 1B) or OVA 230 
(Supplement Fig 2B), was applied to the skin. Two days after the last skin application, the pups 231 
received oral gavage with 100 µg PNE (Fig. 1B) or OVA (Supplement Fig. 2B) and rectal 232 
temperature was monitored. All offspring were FT+/- as determined by genotyping (data not 233 
shown). Anaphylaxis occurred only in the pups that received skin application of HDM or ALT with 234 
food allergens PNE (Fig. 1B) or OVA (Supplement Fig. 2B). Pups with PNE-only or saline on the 235 
skin did not have anaphylaxis with oral challenge so for subsequent experiments, the PNE-only 236 
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skin-treated groups served as the negative control group.  For pups in Fig. 1B, there were no 237 
differences in anaphylaxis by gender (Supplement Fig. 3A) and no differences for gender or 238 
treatment groups in initial body temperature immediately prior to oral challenge (Supplement Fig. 239 
3B). Thus, ALT or HDM were required for skin sensitization with PNE or OVA in the FT+/- pups. 240 
Serum contained anti-PNE specific IgE and IgG2b, but not serum anti-PNE specific IgG1 or 241 
monomeric IgA, in pups with co-application of HDM or ALT with PNE (Fig 1C). There were no anti-242 
PNE specific antibodies in pups with PNE only skin sensitization (Fig. 1C). Serum of OVA 243 
sensitized pups contained anti-OVA-specific IgE with co-application of HDM or ALT with OVA, but 244 
not OVA alone (Supplement Fig 2C). 245 
The pup skin was not exposed to appreciable amounts of endotoxin in PNE, Alt, HDM or 246 
OVA but there wasb considerable endotoxin in fecal pellets in the mouse cage (Supplement Fig. 247 
5). To determine whether ALT or HDM, which may contain proteases, altered the molecular 248 
weights of the major proteins in the PNE, ALT or HDM were incubated with PNE (Supplement Fig. 249 
4). The amounts of ALT, HDM, PNE, Alt/PNE or HDM/PNE, that had been applied to the pup skin 250 
for 40 minutes (Figure 1B), were placed in a tube for 20 or 40 minutes at room temperature and 251 
then examined by SDS-PAGE and staining with Simply Blue protein dye (Supplement Fig. 4). 252 
There was no change in the size of the major protein bands (Supplement Fig. 4). 253 
254 
Skin barrier gene mutations were required for oral food allergen-induced anaphylaxis and 255 
generation of anti-peanut specific IgE in FT+/- offspring of allergic and non-allergic 256 
mothers. To determine whether the mutations in the FT+/- pups were required for the skin 257 
sensitization to food allergens, non-allergic wild type female mice or OVA-allergic wild type female 258 
mice (Fig 2A) were mated with wild type or FT-/- male mice. The OVA-allergic wild type females 259 
were allergic as determined by expression of serum OVA-specific IgE on gestational day 18 260 
(Supplement Fig. 6). The FT+/- pups were skin sensitized with allergen and then received one oral 261 
gavage with PNE as in Fig 2A. Anaphylaxis responses of FT+/- pups of non-allergic mothers 262 
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occurred in the ALT/PNE sensitized pups (Fig. 2B group 2), but not in the pups sensitized with 263 
PNE alone, and not in ALT/PNE-sensitized wild type pups (Fig. 2B Groups 1,3). For pups of 264 
allergic mothers, anaphylaxis responses occurred in the ALT/PNE sensitized or HDM/PNE 265 
heterozygous FT+/- pups (Fig. 2B Groups 5,6) but not in the pups sensitized with PNE alone (Fig. 266 
2B Group 1) and not in wild type pups with skin treatments with saline, PNE, ALT/PNE or 267 
HDM/PNE (Fig 2B Groups 4,7,8,9,10). The Group 2 pups of non-allergic mothers and Group 5 268 
pups of allergic mothers are not significantly different. These data demonstrate that the skin barrier 269 
mutations were required for development of the food allergen responses. 270 
Serum anti-PNE specific IgE was generated in FT+/- pups of non-allergic and allergic 271 
mothers that were sensitized with ALT/PNE but not in the pups sensitized with PNE alone, nor in 272 
the ALT/PNE-treated wild type pups (Fig 2C). Interestingly, the FT+/- pups of allergic mothers also 273 
had elevated relative levels of serum anti-peanut IgG2b (Fig. 2C). There were increased relative 274 
levels of serum anti-PNE specific monomeric IgA in pups of allergic mothers (Fig. 2C Group 5,6) 275 
but not pups of non-allergic mothers (Fig. 1C and 2C Group 2). The role of serum monomeric IgA 276 
in allergy is incompletely understood 59. 277 
278 
Allergic mothers transmitted to FT+/- pups an elevated responsiveness to oral food allergen 279 
anaphylaxis after suboptimal pup skin sensitization. Food allergy in pups of allergic mothers 280 
was examined because, pups of allergic mothers have elevated allergic lung responses to a 281 
suboptimal number of sensitizations with allergen, even if the allergen of the pup differs from the 282 
allergen of the mother 7, 8, 14, 15, 60, 61. This is also evident in humans where family history of allergic 283 
disease is one of the strongest risk factors for development of atopic disease in children 4, 62-66. It is 284 
not known whether offspring of allergic mothers respond to suboptimal food allergen sensitization. 285 
It was determined whether 3 to 6 skin sensitizations were suboptimal in FT+/- pups of non-allergic 286 
mothers but sufficient for anaphylaxis in FT+/- pups of allergic mothers (Fig 3A). The oral challenge 287 
was designed to be at least 13 days after the first skin sensitization to ensure time for activation of 288 
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acquired immune responses including T cell responses and plasma cell generation. After 3 skin 289 
sensitizations, anaphylaxis did not occur in pups of non-allergic mothers, but anaphylaxis did occur 290 
in pups of allergic mothers (Figure 3B upper panel). At 4, 5 or 6 skin sensitizations, the pups of 291 
allergic and non-allergic mothers generated anaphylactic responses (Fig 3B upper panel). The 292 
younger pups had lower basal body temperatures (Supplement Fig 7).  The temperature drops 293 
were greatest in younger pups (Fig. 3B), consistent with the reduced ability of newborns and young 294 
infants to control temperature 67-70. The FT+/-- pups sensitized 3 to 6 times with only PNE did not 295 
exhibit anaphylaxis to PNE (Fig 3B lower panel). Serum anti-peanut IgE was present in FT+/- pups 296 
of allergic mothers after 3 skin sensitizations (Fig 3C middle panel), whereas serum anti-peanut 297 
IgE was only detected after 4 skin sensitizations in pups of non-allergic mothers (Fig 3C right 298 
panel). Furthermore, Alt/PNE skin-treated pups had increased mast cell protease 1 in the serum as 299 
compared to PNE skin-treated pups (Fig 3D). 300 
Cells and mediators of allergic responses were examined in the pups from Figure 3. In the 301 
pups with 6 Alt/PNE skin sensitizations, there was an increase in total number of skin mast cells in 302 
pups of allergic mothers but not pups of non-allergic mothers (Fig 4A,B). Although there was no 303 
increase in mast cell numbers in pups of non-allergic mothers (Fig 4A,B), these mast cells 304 
degranulated (Fig 4C) and the pups underwent anaphylaxis (Fig 3B). The number of degranulated 305 
skin mast cells, a measure of mast cell activation, was increased in Alt/PNE-sensitized pups of 306 
allergic and non-allergic mothers as compared to pups with PNE-only treated skin (Fig 4C). There 307 
were more degranulated skin mast cells in Alt/PNE-sensitized pups of allergic as compared to 308 
Alt/PNE-sensitized pups of non-allergic mothers (Fig 4C). Skin and blood eosinophils were also 309 
increased in pups sensitized with Alt/PNE as compared to pups with PNE-only treated skin (Fig 310 
4D-F). Skin and blood of Alt/PNE sensitized pups of allergic mothers had significantly more 311 
eosinophils than those of non-allergic mothers (Fig 4D-F). Since allergic inflammation is initiated in 312 
epithelial tissues by production of cytokines and chemokines, it was determined whether skin 313 
sensitization induced skin expression of CCL11, thymic stromal lymphopoietin (TSLP), and IL-33.  314 
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CCL11, TSLP and IL-33 were increased in skin of pups with skin applications of Alt/PNE for pups 315 
as compared to pups with PNE-only treated skin (Fig 4G). Moreover, at 3 skin applications of 316 
Alt/PNE, the pup skin of allergic mothers had higher amounts of CCL11 and TSLP than the skin of 317 
pups from non-allergic mothers (Fig 4G). At 6 skin applications, there was no difference in CCL11 318 
and TSLP for Alt/PNE treated pups of allergic and non-allergic mothers, suggesting that maximal 319 
induction may have occurred.  In pups with 6 skin applications, TSLP was also elevated in the 320 
jejunum at 6 hrs after only a single oral gavage with PNE (Fig 4G). Eosinophils and degranulated 321 
mast cells were similarly increased in the intestines of the Alt/PNE sensitized pups of allergic and 322 
non-allergic mothers as compared to pups with PNE-only skin-treated pups (Fig. 5). 323 
324 
Anti-ST2 administration at time of skin sensitization blocked oral antigen-induced 325 
anaphylaxis. IL-33 has a key role in initiation of allergic responses in skin and lung 71, 72, regulates 326 
mast cells 73, 74 and reduces anaphylaxis in a food model with 49 days of sensitization 75. In Figures 327 
3-6, IL-33 was increased and mast cells degranulated in the skin and intestine. Therefore, we328 
determined whether blocking the IL-33 receptor, ST2, blocks anaphylaxis. FT+/- pups were treated 329 
with blocking anti-ST2 antibodies or IgG2b isotype control antibodies 1 hr before each skin 330 
sensitization as in Figure 6A,B. Anti-ST2, but not the isotype control antibody, blocked oral-PNE-331 
induced anaphylaxis (Fig. 6B), blocked the increase in anti-PNE-specific IgE, IgG2b and IgG1 (Fig. 332 
6C) and blocked the increase in serum Mcpt-1 (Fig. 6D). 333 
334 
Oral pre-exposure to PNE induced tolerance but this was less effective when the FT+/- pup 335 
skin was exposed to the ubiquitous environmental allergen Alt. Recent clinical data from the 336 
“Learning Early about Allergy to Peanut” (LEAP) study suggests that early life oral introduction of 337 
peanut reduces the frequency of development of peanut allergy 76, 77. Whether early introduction of 338 
oral peanut prevents food allergen sensitization by cutaneous skin exposure is not known. We 339 
determined whether daily oral gavage on PND 3, 4, 5, and 6 with PNE in Tris-buffered saline (TBS) 340 
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reduces FT+/- pup skin sensitization as compared to administration of the solvent control TBS (Fig 341 
7A). After oral administrations, all pups received 5 skin applications of Alt/PNE on PND 6, 8, 10, 14 342 
and 18 (Fig 7A). Pre-exposure to PNE by oral gavage blocked the development of anaphylaxis in 343 
FT+/- pups of non-allergic mothers (Figure 7B) and allergic mothers (Figure 8B). Wild type pups 344 
did not develop anaphylaxis (Fig 7B). Remarkably, for FT+/- pups of allergic mothers or non-345 
allergic mothers (Fig 8B), skin exposures to Alt concurrent with each oral pre-exposure to PNE 346 
reduced the protective effect and had anaphylaxis (Fig 8B Group 4 and 7 and Supplement Fig. 8). 347 
Mediators of initiation of allergic responses were assessed at 6 hours after the PND20 oral 348 
PNE gavage for pups in Fig 7B. Alt/PNE-sensitized FT+/- pup intestines had increased TSLP and 349 
IL-33 (Fig 7C-E Group 3). This increase in TSLP was blocked by PND3-6 pre-exposure with oral 350 
PNE (Fig 7C-E Group 4). Pups that had 4 pre-exposures to Alt only before skin sensitization had a 351 
significant increase in antibodies (Fig 8C Group 3) as compared to skin sensitization without the Alt 352 
pre-exposures (Fig 8C Group 1 or 5). Interestingly, the Alt-PNE-induced anti-PNE-specific IgE, and 353 
IgG2b antibodies (Fig 7F Group 3) were blocked by pre-exposure oral PNE (Fig 7F Group 4). 354 
However, the reduction in anti-PNE-specific IgE (Fig 8C Group 1 compared to Group 2 and Fig 8C 355 
Group 5 compared to Group 6) was less effective when there was skin pre-exposure to Alt on 356 
PND3-6 at the time of pre-exposure with oral PNE (Fig 8C Group 1 compared to Group 4 and Fig 357 
8C Group 5 compared to group 7). 358 
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Discussion 360 
We demonstrated that neonatal mice heterozygous for skin barrier mutations develop food 361 
allergy by skin sensitization with food allergens and co-exposure to Alt or HDM. The skin barrier 362 
mutations and Alt or HDM were required to drive the development of food allergen sensitization, 363 
food-induced anaphylaxis, and inflammation and cytokines in the skin and intestine. Blocking ST2 364 
during skin sensitization blocked anaphylaxis by FT+/- pups. The FT+/- neonates of allergic WT 365 
mothers had anaphylaxis and elevated serum allergen-specific IgE to suboptimal skin challenges 366 
as compared to FT+/- neonates of non-allergic WT mothers. Skin pre-exposure to the ubiquitous 367 
environmental allergen Alt reduced oral-PNE-induced tolerance in the presence of skin barrier 368 
mutations. These data demonstrate mechanisms for potent and rapid development of food 369 
allergies in offspring heterozygous for skin barrier mutations. 370 
Animal studies of food allergy have included food exposure with bacterial toxins or 371 
prolonged antigen exposure. For instance, in small and large animals, food allergy models include 372 
sensitization of adult mice by oral administration of food antigens with cholera toxin or 373 
intraperitoneal injection of food antigens with alum 78. In studies with prolonged allergen exposure, 374 
OVA sensitization of adult mice is induced by a 49 day protocol with tape stripping and OVA skin 375 
patches held by semi-permeable Tegaderm tape; this tape prevents the passage of liquids and 376 
microbes while allowing moisture vapor and gas exchange 79. Since mice are weaned at 21 days, 377 
the 49 days precludes the ability to analyze development of food allergy in neonates, the time 378 
when food allergy often develops in humans. In contrast, our studies demonstrate neonate 379 
anaphylaxis with up to a 3oC temperature drop after rapid sensitization by 3 to 4 skin exposures to 380 
allergens.  In another study, adult wild type mice were skin sensitized to OVA or peanut by two 381 
weeks of daily tape stripping  and concurrent application of an adjuvant Calcipotriol (MC 903) but 382 
in these studies, gavage with PNE decreased body temperature by only about 0.5oC 58. It is 383 
reported that skin exposure to OVA in PBS exacerbates spontaneous skin inflammation in 384 
homozygous flaky tail mice but not in heterozygous FT+/- mice 80. Consistent with this, in our 385 
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studies with heterozygous FT+/- mice, PNE alone did not induce skin inflammation. However, we 386 
demonstrated that, in heterozygous FT+/- neonatal mice, Alternaria alternata drove a robust food 387 
allergen-induced allergic inflammation and anaphylaxis. Thus, exposure to food allergens along 388 
with components of house dust may potently sensitize individuals with skin barrier mutations early 389 
in life. 390 
Initiation of allergic responses at epithelial tissues in skin or lungs of adult mice is regulated 391 
by production of innate cytokines such as IL-33, and TSLP 18, 81, 82. An increase in expression of 392 
CCL11 and IL33 is also associated with human atopic dermatitis 33. In our report, sensitization by 393 
skin application of Alt/PNE on FT+/- neonates increased skin TSLP, CCL11, IL-33 and eosinophils 394 
and increased intestine TSLP, demonstrating that there is induction of signals for initiation of 395 
allergic responses. In a 49 day skin sensitization protocol, blockade of the IL33 receptor, ST2, just 396 
before oral challenge, significantly reduced the severity of oral anaphylaxis 75. We demonstrate 397 
that blockade of ST2 before each skin sensitization completely blocked oral antigen-induced 398 
anaphylaxis. Thus, ST2 plays a key role in the development of anaphylaxis.  399 
Food-specific IgE is low in food allergic children and correlates poorly with food allergy 4. 400 
IgG1 can also mediate peanut antigen-induced anaphylaxis in the absence of IgE in animal models 401 
83
. In adult mice, IgE is necessary but not sufficient for oral food anaphylaxis in a model with OVA402 
sensitization in a protocol with 49 days of tape stripping and OVA skin patches 79. In our studies 403 
with only 3 skin sensitizations with PNE/Alt in neonatal FT+/- mice, there was anaphylaxis to oral 404 
antigen challenge despite very low anti-PNE IgE levels. This is consistent with reports in humans 405 
that food antigen-specific antibodies are not always associated with food responses and may be 406 
below detection in the serum. At low antigen-specific serum antibody concentrations with allergen 407 
responses, the antibodies are likely in tissues bound to Fc receptors on inflammatory cells. Our 408 
ongoing studies are determining functions of the antibodies and Fc receptors. 409 
Allergic lung responses to low dose allergen have been reported to be elevated in offspring 410 
of allergic mothers and these offspring responses are not specific to the allergen that the mother 411 
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had been exposed 6-12, 14, 15, 55, 60, 61, 84. We demonstrated that the allergen to which the mother 412 
responds (OVA) can be different than the food allergen (PNE) of the offspring and we demonstrate 413 
that offspring of the allergic mothers respond to a protocol that is suboptimal for offspring of non-414 
allergic mothers. Our ongoing studies are determining maternal factors of allergic mothers that 415 
contribute to food allergy in FT+/- neonates. 416 
Tolerance to food allergens hasg been studied in humans and mice. The clinical “LEAP” 417 
studies suggest that early life oral introduction of peanut at 4 to 11 months old reduces the 418 
frequency for development of peanut allergy in children 76, 77. Tolerance to food allergens has been 419 
studied in adult but not neonatal mice. Briefly, low dose pre-exposure of allergic mother mice to 420 
peanut during pregnancy and lactation protects 5 week old adult offspring from sensitization with 421 
oral peanut plus cholera toxin, but protection in the Th2 environment of neonates was not studied 422 
85
. Also, aerosolized OVA exposure of non-allergic mother mice during pregnancy protected 1 to 4423 
month old adult offspring from intraperitoneal sensitization with OVA 86. In contrast, in another 424 
report, maternal exposure to peanut during mouse pregnancy and lactation did not protect 425 
development of anti-peanut antibodies in adult 5 week old offspring that received peanut with alum 426 
adjuvant twice at 2 week intervals; however, when the 5 week old adult offspring were fed peanut 427 
for 5 days before sensitization with peanut/alum, antibody generation was reduced 87. In another 428 
study with adult mice, pre-exposure for 6 days with OVA in the drinking water blocks development 429 
of atopic dermatitis induced by in a 49 day sensitization protocol with OVA-loaded skin patches 430 
that were held on the skin with semi-permeable Tegaderm tape 88. We demonstrated that tolerance 431 
can be induced in neonatal mice. In neonatal FT+/- mice, anaphylaxis to food allergen was 432 
prevented by pre-exposure with oral PNE before skin sensitizations with PNE/Alt. Of potential 433 
concern for individuals with skin barrier mutations, in the neonatal FT+/- mice, skin application with 434 
the ubiquitous allergen Alt at the same time of pre-exposure with oral PNE reduced the induction of 435 
tolerance to PNE. Future studies will address mechanisms of Alt inhibition of oral tolerance. 436 
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In humans, child peanut allergy associates with exposure to peanut in household dust, 437 
exposure of peanut oils to inflamed skin in children, and household peanut consumption associate 438 
with child peanut allergy 89-91. House dust also contains Alt and HDM. Thus in the environment of 439 
infants and children, there is often ubiquitous exposure to HDM, Alt and food allergens. 440 
Specifically, household dust contains peanut allergens at a level of 5 to 2200 µg peanut/ g 441 
household dust 45, Alt at 0.1 to 100 µg/ g household dust 46, 47, and HDM antigens at about 12 µg 442 
DerP1DerP2/ g dust 43, 44. In our cause and effect studies, the neonatal FT+/- mice received a 40 443 
minute skin exposure of 10 µg Alt and 100 µg PNE every 3-4 days, which is within range for skin 444 
exposures in the household environment, and developed anaphylaxis after oral challenge. At these 445 
doses, there was no synergy of Alt with HDM (Fig. 1), suggesting that these doses found in house 446 
dust provide maximal sensitization through either Alt or HDM in the presence of skin barrier 447 
mutations. 448 
In infants and children, loss-of-function mutations in skin barrier mutations associate with 449 
peanut allergy 36, 90, 92, 93. Also, IgE-mediated food allergy is observed in up to 35% in children 450 
affected with atopic dermatitis 29. Other reports predict that there are additional factors involved in 451 
development of food allergy 92. Another factor may be soap components such as sodium lauryl 452 
sulfate, which is SDS, in cleansing wipes which may facilitate allergen uptake during feeding and 453 
cleaning of infants with skin barrier mutations. We report that other factors such as skin exposure 454 
of environmental allergens along with application of SDS can readily sensitize food allergen 455 
responsiveness in neonatal mice. In our studies, SDS facilitated absorption of the topical 456 
application of the allergens whereas without the SDS the liquid droplet containing allergen 457 
remained as a droplet and the droplet rolled off of the skin. To translate our findings to humans and 458 
their environment, for an infant that has skin barrier mutations, food allergen sensitization may 459 
occur very early in life by skin exposure to food allergens and concurrent skin exposure to soap in 460 
cleansing wipes and to house dust mites, Alternaria alternata and food allergens in house dust, 461 
bedding, blankets and flooring, and when handled by family members that are preparing or eating 462 
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food. Moreover, these skin exposures occur early in infancy before clinical manifestations of atopic 463 
dermatitis. In children with Flg mutations, barrier defects precede clinical eczema diagnosis 94. 464 
Interestingly, in our studies, skin sensitization occurred in the neonatal mice with skin barrier 465 
mutations well before the development of spontaneous atopic dermatitis skin lesions that develop 466 
months later in FT-/- mice 38. Furthermore, early pre-exposure to oral allergen before exposure to 467 
environmental allergy blocked development of anaphylaxis.  This is consistent with a randomized, 468 
double-blind, placebo-controlled clinical trial that demonstrated that egg allergy is prevented by 469 
restoration of skin barrier function and early oral introduction of egg 95.  Future clinical food allergy 470 
studies in neonates and infants are needed to determine effects of food allergen when stratifying 471 
individuals by loss of skin barrier function before their development of atopic dermatitis 94.  472 
In summary, these studies demonstrate mechanisms for development of food allergy driven 473 
by skin sensitization with environmental allergens in house dust and by skin barrier mutations. This 474 
is consistent with many features of early life exposures and genetics in clinical food allergy. 475 
Moreover, offspring of allergic mothers had elevated responses to a limited number of skin 476 
exposures indicating that there is a maternal factor contributing to the development of food allergy. 477 
These studies of mechanisms for development of food allergen sensitization provide a basis 478 
towards designing studies to test interventions that more effectively modulate these pathways in 479 
allergic disease. Currently, avoidance of triggering food allergens is a main treatment, with a 480 
profound negative impact on quality of life 96. More studies are needed in humans to examine 481 
mechanisms for development of food allergy and mechanisms for induction of tolerance to food 482 
allergens early in life. 483 
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Figure Legends 730 
Figure 1. Skin sensitization of neonates with skin barrier gene mutations induced responsiveness 731 
to oral food allergen-induced anaphylaxis. (A) Timeline for mating and for FT+/- pup 732 
treatments with food and environmental allergens. (B) Food allergen-induced temperature 733 
(oC) changes on day 21. (C) Anti-peanut specific serum IgE, IgG1, IgG2b, and IgA as 734 
determined by ELISA. N=8-10/group. The data in all figures include both genders for pups 735 
because there were no differences in outcomes by gender (Supplement Data Figure 2). *, 736 
p<0.05 as compared to the saline skin-sensitized group and the PNE-only skin-sensitized 737 
group. Alt, Alternaria alternata extract; FT-/-, flaky tail mice homozygous for filaggrin and 738 
mattrin mutations; FT+/-, flaky tail mice heterozygous for filaggrin and for mattrin mutations; 739 
HDM, house dust mite extract; OVA, chicken egg ovalbumin; PND, postnatal day; PNE, 740 
peanut extract; WT, wild type. 741 
742 
Figure 2. Skin barrier gene mutations are required for oral food allergen-induced anaphylaxis and 743 
generation of anti-peanut specific IgE in FT+/- offspring of allergic and non-allergic mothers. 744 
(A) Timeline for mating of females with FT-/- males or WT males and for pup treatments745 
with food and environmental allergens. (B) Food allergen-induced temperature changes on 746 
day 21.  (C) Anti-peanut specific antibodies were measured by ELISA. Serum was from 747 
pups in Figure 2B. Anti-peanut specific serum IgE was measured using a 1/10 serum 748 
dilution and a 12 minute TMB color development. Anti-peanut specific serum IgG2b was 749 
measured using a 1/1000 serum dilution and a 12 minute TMB color development. Anti-750 
peanut specific serum IgG1 was measured using a 1/20,000 serum dilution and a 6 minute 751 
TMB color development. Anti-peanut specific monomeric serum IgA was measured using a 752 
1/10 serum dilution and a 30 minute TMB substrate color development. N=8-10/group. *, 753 
p<0.05 as compared to the corresponding PNE only skin-sensitized groups, ie as 754 
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compared group 1 for FT+/- pups of saline treated mothers, as compared to group 4 of 755 
FT+/- pups of allergic mothers.  For WT pups, there was no difference as compared to 756 
group 8. Alt, Alternaria alternata extract; FT-/-, flaky tail mice homozygous for filaggrin and 757 
mattrin mutations; FT+/-, flaky tail mice heterozygous for filaggrin and for mattrin mutations; 758 
HDM, house dust mite extract; PND, postnatal day; PNE, peanut extract; WT, wild type. 759 
760 
Figure 3. Allergic mothers transmitted to FT+/- pups an elevated responsiveness to oral food 761 
allergen anaphylaxis after suboptimal pup skin sensitization. (A) Timeline for induction of 762 
OVA-induced lung inflammation in females, mating of females with FT-/- 763 
(FLGft/ft/Tmem79ma/ma) males or WT males, and for pup treatments with food and 764 
environmental allergens. (B) Food allergen-induced temperature changes after oral gavage 765 
on days 13, 15, 19 or 22. (C) Serum was from pups in (B). In the panel on the left, anti-766 
peanut specific serum IgE was measured using a 1/10 serum dilution and a 12 minute TMB 767 
substrate color development. In the two panels on the right, anti-peanut specific serum IgE 768 
was measured using a 1/2 serum dilution and a 20-30 minute TMB color development. (D) 769 
Serum Mcpt-1 was measured by ELISA. N=8-10/group. *, p<0.05 as compared to the 770 
corresponding PNE only skin-treated group. **, p<0.05 as compared to the indicated 771 
groups of Alt/PNE-treated pups from non-allergic saline-treated mothers.  772 
773 
Figure 4. Skin Inflammation and mediators of allergic responses are elevated in Alt/PNE skin 774 
sensitized FT+/- pups. Pup skin tissues from the site of skin sensitizations and pup blood 775 
from the pups in Figure 4B. (A) Shown are representative micrographs of toluidine-stained 776 
pup skin tissue sections from the site of 6 skin sensitizations and skin collected on PND22. 777 
Black arrows indicate mast cells. Yellow arrow indicates a degranulated mast cell. (B) Pups 778 
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had 6 skin sensitizations (6xss) and skin was collected on PND22. Presented is the number 779 
of skin mast cells in 10 high powered fields at 40x (HPF) per pup tissue section from 8-10 780 
pups. (C) Pups had 6 skin sensitizations and skin was collected on PND22.  Presented is 781 
the number of degranulated skin mast cells in 10 high powered fields at 40x (HPF) per pup 782 
tissue section from 8-10 pups.  (D) Shown are micrographs of eosin-stained skin tissue 783 
section with a light hematoxylin counter stain from pups with 6 skin sensitizations and skin 784 
collected on PND22. Black arrows indicate eosinophils. (E) Number of eosinophils in 10 785 
high powered fields at 40x (HPF) from pups with 6 six sensitizations and skin collected on 786 
PND22. (F) Number of blood eosinophils as determined by discomb staining and 787 
hemacytometer counting from pups with 6 skin sensitizations and blood collected on 788 
PND22. (G) RT-qPCR of pup skin TSLP and CCL11 for pup skin after 3 skin sensitization 789 
(3x ss) with skin collected PND12 or 6 skin sensitizations (6xss) with skin collected on 790 
PND22. RT-qPCR of IL-33 after 4 skin sensitizations (4x ss) with skin collected PND16.  791 
RT-qPCR of TSLP for jejunum from pups with 6 skin sensitizations (6x ss) and intestine 792 
collection on PND22. N=8-10/group. *, p<0.05 as compared to the corresponding PNE only 793 
skin-treated group. **, p<0.05 as compared to the Alt/PNE-treated pups from non-allergic 794 
saline-treated mothers and compared to corresponding PNE skin-treated group from 795 
allergic mothers.  796 
797 
Figure 5. Intestinal Inflammation is elevated in Alt/PNE skin-sensitized FT+/- pups. Intestines were 798 
collected from pups from Figure 4B with 4 skin sensitizations. (A) Shown are micrographs 799 
of eosin-stained intestine tissue section with a light methyl-green counter stain. Black 800 
arrows indicate eosinophils. Box insert contains enlarged image of eosinophil indicated by 801 
dotted line. (B) Number of eosinophils per high powered 64x field (HPF) of pup intestine 802 
tissue section.  (C) Shown are representative micrographs of toluidine-stained pup intestine 803 
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tissue sections. Open arrows indicate degranulated purple mast cells. Closed black arrows 804 
indicate intact dark purple mast cells. (D) Percent degranulated mast cells per intestine 805 
tissue slice.  (E) Number of cells per pup intestine tissue slice. N=8-10/group. *, p<0.05 as 806 
compared to the corresponding PNE only skin-treated group.  807 
808 
Figure 6. Anti-ST2 blocked development of oral food allergen-induced anaphylaxis. (A) Timeline for 809 
mating of females with FT-/- males or WT males, for antibody (Ab) treatment one hour 810 
before pup skin sensitization on PND3-13 with food and environmental allergens. FT+/- 811 
pups received an intraperitoneal injection of 8 8 µg anti-ST2 or IgG2b isotype control at 1 hr 812 
before skin sensitization #1, 12 µg antibody/g pup at 1 hr before skin sensitization #2 and 813 
#3, and then 15 µg antibody/g pup at 1 hr before skin sensitization #4. (B) Food allergen-814 
induced temperature changes after oral gavage on postnatal day 15. (C) Anti-peanut 815 
specific IgE, IgG2b, IgG1 and monomeric IgA in serum from pups in panel B. (D) Serum 816 
Mcpt-1 was measured by ELISA.  *, p<0.05 as compared to groups, 1, 3, 5 and 6.  817 
818 
Figure 7. Oral pre-exposure to PNE induced tolerance in FT+/- pups. (A) Timeline for induction of 819 
mating of females with FT-/- males or WT males, for pup pre-exposures on PND 3-6, and 820 
for pup skin treatments on PND6-18 with food and environmental allergens. Intestines were 821 
flushed with saline before RT-qPCR analysis (B) Food allergen-induced temperature 822 
changes after oral gavage on days 20. *, p<0.05 as compared to all other groups. For pups 823 
from panel B, shown is the RT-qPCR of (C) pup skin TSLP, (D) pup intestine TSLP, and (E) 824 
pup ileum IL-33. (F) Anti-peanut specific serum IgE, IgG2b, IgG1 and IgA from pups in 825 
panel 2 as determined by ELISA. TBS, Tris-buffered saline.  *, p<0.05 as compared to 826 
groups 1, 2, and 4. 827 
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828 
Figure 8.  Oral pre-exposure to PNE to induce tolerance in FT+/- pups was less effective when 829 
their skin was pre-exposed to the ubiquitous environmental allergen Alt during oral pre-830 
exposure to PNE. (A) Timeline for induction of OVA-induced lung inflammation in females, 831 
mating of females with FT-/- males, for pup pre-exposures on PND 3-6, for pup skin 832 
sensitization on PND6-18 with food and environmental allergens and for oral challenge on 833 
PND 20. (B) Food allergen-induced temperature changes after oral gavage on day 20. *, 834 
p<0.05 as compared to the group without the asterisk. (C) Anti-peanut specific serum IgE, 835 
IgG2b, IgG1 and monomeric IgA from pups in panel B as determined by ELISA. *, p<0.05 836 
as compared to all groups without one asterisk. **, p<0.05 as compared to indicated group. 837 
N=8-10 pups/group. 838 
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Supplemental Methods 830 
831 
Tissue analysis of inflammatory mediators. At the indicated day in the figures, the pups were 832 
weighed, euthanized and tissues collected. Peripheral blood was collected in heparin tubes and 833 
blood eosinophils were counted in a 1:10 dilution in Discomb stain (one part acetone, one part 834 
2% aqueous eosin, and eight parts distilled water) 1, 2. The eosin positive eosinophils were 835 
counted using a hemacytometer (catalog #0267110, Fisher Scientific) 3. 836 
Serum was collected for analysis of antigen-specific antibodies. Skin punches and intestines 837 
were collected for histology or qPCR of mediators of inflammation. Neonate intestines were 838 
flushed with saline and fixed with 4% formaldehyde in PBS overnight followed by 30 minutes in 839 
30% sucrose in PBS. The intestines were frozen in OCT and stored at -80oC. Intestine tissue 840 
sections were stained with 0.1% toluidine blue (0.1% toluidine blue in 7% ethanol, 1% NaCl, 841 
ph2.3) for mast cells or with  eosin and a light methyl-green counterstain (EMG stain) for 842 
eosinophils 3. Paraffin-embedded skin tissue sections were processed for histology with 843 
toluidine blue for mast cells or with an eosin and light hematoxylin counterstain for eosinophils. 844 
845 
RNA Isolation and Quantitative Real-Time PCR. RNA extraction was performed using the 846 
RNeasy Mini Kit (QIAGEN), and cDNA was generated using the Applied Biosystems High-847 
Capacity cDNA Archive Kit. The qRT-PCR analysis was performed with a 7500 Fast Real Time 848 
PCR System (Applied Biosystems). Reactions were set up with the SYBR™Green PCR Core 849 
Reagents (Invitrogen). Data were normalized to GAPDH, and mRNA expression fold-change 850 
relative to controls was calculated using the 2−∆∆Ct method. 851 
852 
PNE-specific antibody, OVA-specific antibody, and MCPT-1 ELISAs. Serum anti-peanut 853 
IgE, IgG1, IgG2a and IgA were determined by ELISA. Briefly, high binding 96 well EIA/RIA plate 854 
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(Fisher Sci catalog #50-823-480) were coated with 50 µl of 10µg PE protein/ml in carbonate 855 
buffer for 2 hours at room temperature. Plates were washed with PBS-0.05%Tween and 856 
blocked with PBS + 3% BSA for 2 hours at room temperature. Plates were washed with PBS-857 
Tween and incubated overnight with serum diluted as indicated in figures in PBS + 1% BSA. 858 
Plates were washed with PBS-0.05%Tween and incubated for 1 hour at room temperature with 859 
100 µl of 2µg/ml biotin-labeled secondary antibody in PBS-1% essentially immunoglobulin-free 860 
BSA. Plates were washed with PBS-Tween and incubated with 100 µl /well streptavidin-HRP 861 
(1:1000 dilution in PBS, GE Healthcare, catalog #RPN1231-2ML). Plates were washed in TBS-862 
Tween and incubated with 100 µl TMB substrate (eBioscience catalog#00-4201-56, 3,3',5,5'-863 
Tetramethylbenzidine; HRP substrate). At the indicated times in the figures, the reaction was 864 
stopped with 100 µl 2M phosphoric acid and plates read at 450nm in a microtiter plate reader.  865 
 Serum anti-OVA IgE were determined by ELISA. Briefly, high binding 96 well EIA/RIA plate 866 
(Fisher Sci cat#50-823-480) were coated with 100 µl of 0.3 µg anti-IgE (clone R35-72, catalog 867 
#553413, BDPharMingen) in carbonate buffer overnight at 4oC. Plates were washed with PBS-868 
0.05%Tween and blocked with PBS-3% essentially immunoglobulin-free BSA (Sigma) for 2 869 
hours at room temperature. Plates were washed with PBS-0.05%Tween and incubated 870 
overnight with anti-OVA IgE standard (catalog # MCA2259, ABDserotec) or serum as indicated 871 
in figures in PBS + 1% BSA. Plates were washed with PBS-0.05%Tween.  Plates were 872 
incubated with 100 ul with 0.2 ug biotin-OVA for 1 hour at room temperature. Plates were 873 
washed with PBS-0.05%Tween and incubated with 100 µl /well streptavidin-HRP (1:1000 874 
dilution in PBS, GE Healthcare, catalog #RPN1231-2ML). Plates were washed in TBS-Tween 875 
and incubated with 100 µl TMB substrate (eBioscience catalog#00-4201-56, 3,3',5,5'-876 
Tetramethylbenzidine; HRP substrate). The reaction was stopped with 100 µl 2M phosphoric 877 
acid and plates read at 450nm in a microtiter plate reader.  878 
 MCPT-1 in serum was measured by ELISA according to manufacturer’s instructions (catalog 879 
#50-174-16, Fisher Scientific). 880 
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881 
Endotoxin levels.   Endotoxin was measured with modifications of the manufacturer’s 882 
instructions for the Pierce Limulus Amebocyte Lysate (LAL) Chromogenic Endotoxin 883 
Quantification Kit (catalog #88282, Thermo Fisher Scientific). LAL can be activated by endotoxin 884 
or β-glucan 4.  Therefore, to specifically measure endotoxin, β-glucan activation of LAL 4 was 885 
blocked by addition of heat inactivated laminarin to the assay.  Briefly, 5 mg/ml laminarin 886 
(catalog #L9634, Sigma) in 0.2 N NaOH was heat inactivated at 56oC for 6 hr, stored at -20oC 887 
until used, and then added to LAL in the endotoxin kit at a concentration of 20 µg/ml heat-888 
inactivated laminarin. 889 
890 
 Genotyping for Flgft and Tmem79ma. Offspring of the mating of wild type C57BL/6 females 891 
with Flgft/ft /Tmem79ma/ma males were confirmed by genotyping. Briefly, for Flg PCR detection, 892 
murine genomic DNA was isolated from tail clips using the Quantabio Extracta DNA Prep kit 893 
(catalog #95091) and amplified with the primers: Forward: 5’-CATCTCCAGTCAGGGCTGACC-894 
3’, Reverse: 5’-GCTGCCTGTGGCCGGACTCG-3’. PCR amplification conditions were as 895 
follows: (96°C, 5 min) x1; (96°C 30sec, 60°C 30sec,  72°C 30 sec) x35; (72°C, 5 mins) x1. 896 
Amplified transcripts were then digested with the restriction enzyme Acc I (New England 897 
Biolabs, catalog #R01611s) yielding either a wild type FLG band at 678bp or two fragments of 898 
the mutant FLG at 559bp and 134bp as determined by gel electrophoresis. 899 
900 
SDS/PAGE analysis of allergens. Peanut extract was incubated at room temperature with or 901 
without Alternaria alternata extract for 40 minutes in the same protein ration as applied to the 902 
neonatal mice. SDS-PAGE was performed with 10% Acrylamide gels. The gels were stained 903 
with SimplyBlue™ SafeStain (catalog #LC6060, Thermo Fisher) and imaged with an Odysey 904 
CLx (Licor). 905 
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Supplement Figure legends. 
Supplement Figure 1. FT+/- Pups were treated with 3 skin applications of Alt/PNE as in 
Figure 1. A,B) Representative images of pup skin after gentle paper taping on PND3 and PND6 
to gently remove dry shedding skin after birth. C) Representative image of pup skin on PND9 
after shaving and then taping with paper tape to remove loose shaved fur. 
Supplement Figure 2. OVA/Alt or OVA/HDM skin sensitization of FT+/- neonates induced 
responsiveness to anaphylaxis. (A) Timeline for mating and for FT+/- pup treatments. (B) 
Food allergen-induced temperature (oC) changes on day 21. (C) Anti-OVA specific serum IgE,. 
N=8-10/group. *, p<0.05 as compared to the saline skin-sensitized groups. 
Supplement Figure 3.  There were no differences in response by gender and no 
differences in pup body temperature by gender prior to oral challenge.  (A) These are the 
same data as from Figure 1 but separated here by gender. *, p<0.05 as compared to the saline 
skin-sensitized groups. (B) For pups from Figure 1, there was no differences in initial body 
temperature by gender or treatment just prior to oral challenge on PND21.  
Supplement Figure 4. There was no indication of any new major band sizes after co-
incubation of Alt with PNE or co-incubation of HDM with PNE.  Co-incubation of PNE with 
(A) Alt or (B) HDM at room temperature for 20 or 45 minutes followed by SDS-PAGE and
staining with simply blue. Indicated are the sizes for the major peanut proteins (AraH1, AraH3
acidic subunits, AraH3 basic subunit, AraH2, AraH6.
Supplement Figure 5. Endotoxin amounts in fecal pellets in mouse cage and in allergens 
for each skin treatment. Endotoxin was measured by the LAL chromogenic assay.  Presented 
is endotoxin for each fecal pellet in cage bedding, 100 µg PNE,  10µg Alt, 10 µg HDM and 100 
µg OVA, because these are the amounts applied to the skin at each treatment. *, p<0.05 as 
compared to other groups. 
Supplemental Figure 6. The OVA allergic female mothers had OVA-specific serum IgE. 
These are allergic and saline-treated mothers that were treated as in Figure 2. Serum was 
collected on GD18 and OVA-specific IgE measured by ELISA. *, p<0.05. 
Supplement Figure 7.  Initial body temperature measured immediately before oral 
challenge increased with age but did not differ between pups of saline-treated and 
allergic mothers. Shown are initial body temperatures measured immediately before oral 
challenge for pups in Figure 3. *, <0.05 as compared to corresponding group with one fewer 
skin sensitization.   
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Supplement Figure 8. Data here are for ease of side-by-side comparisons for data from 
Figures 7 and 8.  The data in figure 7 and 8 were from the same very large experiment.  These 
are the data from Figure 7 groups 3&4 and Figure 8 groups 3&4. Oral pre-exposure to PNE to 
induce tolerance in FT+/- pups was less effective (Fig8 group 4) when their skin was pre-
exposed to the ubiquitous environmental allergen Alt during oral pre-exposure to PNE as 
compared to the induction of tolerance with Oral PNE in the absence of Alt pre-exposure (Fig7 
group 4). *, p<0.05 as compared to the group without the asterisk. 
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